BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15340261)

  • 1. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
    Arver B; Haegermark A; Platten U; Lindblom A; Brandberg Y
    Fam Cancer; 2004; 3(2):109-16. PubMed ID: 15340261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
    Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
    J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of receiving a BRCA1/BRCA2 test result.
    Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
    Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
    Pasacreta JV
    Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.
    Vadaparampil ST; Ropka M; Stefanek ME
    Fam Cancer; 2005; 4(2):195-206. PubMed ID: 15951974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
    Watson M; Foster C; Eeles R; Eccles D; Ashley S; Davidson R; Mackay J; Morrison PJ; Hopwood P; Evans DG;
    Br J Cancer; 2004 Nov; 91(10):1787-94. PubMed ID: 15505627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment.
    MacDonald DJ; Choi J; Ferrell B; Sand S; McCaffrey S; Blazer KR; Grant M; Weitzel JN
    J Med Genet; 2002 Jul; 39(7):526-30. PubMed ID: 12114489
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
    Claes E; Evers-Kiebooms G; Denayer L; Decruyenaere M; Boogaerts A; Philippe K; Legius E
    J Genet Couns; 2005 Oct; 14(5):349-63. PubMed ID: 16195942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
    Tercyak KP; Demarco TA; Mars BD; Peshkin BN
    Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of BRCA1 testing on women with cancer: a pilot study.
    Wood ME; Mullineaux L; Rahm AK; Fairclough D; Wenzel L
    Genet Test; 2000; 4(3):265-72. PubMed ID: 11142757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial consequences of genetic counseling: a population-based follow-up study.
    Mikkelsen EM; Sunde L; Johansen C; Johnsen SP
    Breast J; 2009; 15(1):61-8. PubMed ID: 19120380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
    Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P
    Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.